Inclusion and exclusion criteria

Inclusion:
  • Squamous cell carcinoma or adenocarcinoma of the esophagus or gastro-esophageal junction 

  • Potentially resectable tumor (cT1b-4aN0-3M0) based on EUS and PET-CT

  • Treatment with neoadjuvant chemoradiation (nCRT) (carboplatin/paclitaxel, 41.4Gy) + esophagectomy

 

Exclusion:
  • Contraindication for MRI or gadolinium contrast 

  • Irradical endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) of the primary tumor before start nCRT

In samenwerking met:

Logo AMC.png

© 2018 Pride Studie - UMCU